GLIOBLASTOMA, IDH-WILDTYPE
Clinical trials for GLIOBLASTOMA, IDH-WILDTYPE explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA, IDH-WILDTYPE trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA, IDH-WILDTYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental drug aims to boost immune attack on aggressive brain tumors
Disease control Recruiting nowThis phase 2 trial tests a new drug called GI-102, alone or with the immunotherapy pembrolizumab, given before surgery to people with recurrent or progressive glioblastoma (a fast-growing brain cancer). The goal is to see if these drugs can increase cancer-fighting immune cells i…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 23, 2026 19:18 UTC
-
Brain cancer breakthrough? new trial delivers drug straight to tumor
Disease control Recruiting nowThis phase III trial is testing whether delivering the drug bevacizumab (Avastin) directly to the brain through a catheter, along with standard chemo and radiation, can help people with newly diagnosed glioblastoma live longer. The study will enroll 432 adults with this aggressiv…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE3 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 23, 2026 19:16 UTC
-
Promising combo therapy for aggressive brain cancer enters final testing phase
Disease control Recruiting nowThis Phase 3 trial tests whether adding lomustine to standard temozolomide chemotherapy improves survival for people with newly diagnosed glioblastoma that has a specific genetic marker (MGMT methylated). About 200 adults aged 18-70 will be randomly assigned to receive either the…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE3 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jun 22, 2026 12:01 UTC
-
New brain scan methods aim to unmask hidden tumor activity
Knowledge-focused Recruiting nowThis study looks at whether advanced imaging methods can give more accurate information about tumor activity in people with newly diagnosed glioblastoma. Standard MRI scans can be confusing because changes after treatment may look like tumor growth but actually be harmless. The s…
Matched conditions: GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:03 UTC